» Articles » PMID: 29042975

Comparison of DWIBS/T2 Image Fusion and PET/CT for the Diagnosis of Cancer in the Abdominal Cavity

Abstract

Fusion images of diffusion-weighted whole-body imaging with background body signal suppression and T2-weighted image (DWIBS/T2) demonstrate a strong signal for malignancies, with a high contrast against the surrounding tissues, and enable anatomical analysis. In the present study, DWIBS/T2 was compared with F-fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography (PET/CT) for diagnosing cancer in the abdomen. Patient records, including imaging results of examination conducted between November 2012 and May 2014, were analyzed retrospectively. In total, 10 men (age, 73.6±9.6 years) and 8 women (age, 68.9±7.1 years) were enrolled into the current study. Of the enrolled patients, 2 were diagnosed with hepatocellular carcinoma, 1 with cholangiocellular carcinoma, 1 with liver metastasis, 2 with pancreatic ductal adenocarcinoma, 1 with renal cell carcinoma and 1 with malignant lymphoma. Benign lesions were also analyzed, including adenomyomatosis of the gallbladder (5 patients), intraductal papillary mucinous neoplasm (4 patients) and right adrenal adenoma (1 case). All the patients with cancer showed positive results on DWIBS/T2 images. However, only 7 out of 8 patients were positive with PET/CT. One patient with right renal cellular carcinoma was positive with DWIBS/T2, but negative with PET/CT. All the patients with benign lesions were negative with DWIBS/T2 and PET/CT. In conclusion, DWIBS/T2 was more sensitive in diagnosing cancer of organs in the abdominal cavity compared with PET/CT. Furthermore, negative results with DWIBS/T2 and PET/CT were useful for the diagnosis of benign lesions, such as adenomyomatosis of the gallbladder and intraductal papillary mucinous neoplasm.

Citing Articles

Clinical Value of Diffusion-Weighted Whole-Body Imaging with Background Body Signal Suppression (DWIBS) for Staging of Patients with Suspected Head and Neck Cancer.

Schicho A, Habicher W, Wendl C, Stroszczynski C, Strotzer Q, Dollinger M Tomography. 2022; 8(5):2522-2532.

PMID: 36287809 PMC: 9607011. DOI: 10.3390/tomography8050210.


Two cases of oligometastatic castration-resistant prostate cancer detected by diffusion-weighted whole-body imaging with background body signal suppression.

Shimizu Y, Nakajima N, Nagao K, Nitta M, Hasegawa M, Kawamura Y IJU Case Rep. 2020; 3(2):65-68.

PMID: 32743473 PMC: 7292150. DOI: 10.1002/iju5.12146.


The Influence of Bowel Preparation on ADC Measurements: Comparison between Conventional DWI and DWIBS Sequences.

Apine I, Baduna M, Pitura R, Pokrotnieks J, Krumina G Medicina (Kaunas). 2019; 55(7).

PMID: 31330916 PMC: 6681204. DOI: 10.3390/medicina55070394.

References
1.
Manenti G, Ciccio C, Squillaci E, Strigari L, Calabria F, Danieli R . Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: Comparison with PET-CT. Eur J Radiol. 2011; 81(8):1917-25. DOI: 10.1016/j.ejrad.2011.08.005. View

2.
Wang N, Zhang M, Sun T, Chen H, Huang Z, Yan L . A comparative study: diffusion weighted whole body imaging with background body signal suppression and hybrid Positron Emission Computed Tomography on detecting lesions in oncologic clinics. Eur J Radiol. 2011; 81(7):1662-6. DOI: 10.1016/j.ejrad.2011.03.047. View

3.
Pietryga J, Morgan D . Imaging preoperatively for pancreatic adenocarcinoma. J Gastrointest Oncol. 2015; 6(4):343-57. PMC: 4502157. DOI: 10.3978/j.issn.2078-6891.2015.024. View

4.
Clancy T . Surgery for Pancreatic Cancer. Hematol Oncol Clin North Am. 2015; 29(4):701-16. DOI: 10.1016/j.hoc.2015.04.001. View

5.
Nechifor-Boila I, Bancu S, Buruian M, Charlot M, Decaussin-Petrucci M, Krauth J . Diffusion weighted imaging with background body signal suppression / T2 image fusion in magnetic resonance mammography for breast cancer diagnosis. Chirurgia (Bucur). 2013; 108(2):199-205. View